SEARCH

SEARCH BY CITATION

References

  • 1
    Longhofer SL, Johnson HC, Culham CA, et al. Effects of a specific thromboxane synthetase inhibitor on thromboxane generation and excretion in healthy dogs. Am J Vet Res 1990; 51:17461750.
  • 2
    Grauer GF, Culham CA, Dubielzig RR, et al. Effects of a specific thromboxane synthetase inhibitor on development of experimental Dirofilaria immitis immune complex glomerulonephri-tis in the dog. J Vet Intern Med 1988; 2:192200.
  • 3
    Ambler J., Butler KD, Ku EC, et al. CGS 129670: a novel, long-acting thromboxane synthetase inhibitor. Br J Pharmacol 1985; 86:497504.
  • 4
    Mangino MJ, Brunt EM, von Doersten P., et al. Effects of the thromboxane synthetase inhibitor CGS 12970 on experimental renal allograft rejection. J Pharmacol Exp Ther 1989; 248:2328.
  • 5
    Hamberg M., Svensson J., Samuelsson B.. Thromboxanes: A new group of biologically active compounds derived from prosta-glandin endoperoxides. Proc Natl Acad Sci USA 1975; 72:29942998.
  • 6
    Granstrom E., Diczfalusy U., Hamberg M.. The thromboxanes. In: Pace-AsciakC., GranstromE., eds. Prostaglandins and Related Substances. Amsterdam : Elseveier, 1983; 4594.
  • 7
    Petrulis AS, Aikawa M., Dunn MJ. Prostaglandin and thromboxane synthesis by rat glomerular epithelial cells. Kidney Int 1981; 20:469474.
  • 8
    Remuzzi G., Imberti L., Rossini C., et al. Increased glomerular thromboxane synthesis as a possible cause of proteinuria in experimental nephrosis. J Clin Invest 1985; 75:94101.
  • 9
    KJotman PE, Smith SR, Volpp BD, et al. Thromboxane synthetase inhibition improves function of hydronephrotic rat kidneys. Am J Physiol 1986; 16:148157.
  • 10
    Cook HT, Cattell V., Smith J., et al. Effect of a thromboxane synthetase inhibitor on eicosanoid synthesis and glomerular injury during acute unilateral glomerulonephritis in the rat. Clin Nephrol 1986; 26:195202.
  • 11
    Stahl RAK, Adler S., Baker PJ, et al. Enhanced glomerular prostaglandin formation in experimental membranous nephropathy. Kidney Int 1987; 31:11261131.
  • 12
    Lianos EA, Andres GA, Dunn MJ. Glomerular prostaglandin and thromboxane synthesis in rat nephrotoxic serum nephritis: effects on renal hemodynamics. J Clin Invest 1983; 72:14391448.
  • 13
    Kelley VE, Sneve S., Musinski S.. Increased renal thromboxane production in murine lupus nephritis. J Clin Invest 1986; 77:252259.
  • 14
    Stork JE, Dunn MJ. Hemodynamic roles of thromboxane A2 and prostaglandin E2 in glomerulonephritis. J Pharmacol Exp Ther 1985; 233:672678.
  • 15
    Zipser R., Meyers S., Needleman P.. Exaggerated prostaglandin and thromboxane synthesis in the rabbit with renal vein constriction. Circ Res 1980; 47:231237.
  • 16
    Boot JR, Dawson W., Kitchen EA. The chemotatic activity of thromboxane B2: A possible role in inflammation. J Physiol 1976; 257:4748.
  • 17
    Mene P., Dunn MJ. Contractile effects of thromboxane A2 and endoperoxide analogues on cultured rat glomerular mesangial cells. Am J Physiol 1986; 251:F1029F1035.
  • 18
    Baylis C.. Effects of administered thromboxane on the intact, normal rat kidney. Renal Physiol Basel 1987; 10:110121.
  • 19
    Longhofer SL, Culham CA, Frisbie DD, et al. Effects of thromboxane synthetase inhibition on immune complex glomerulonephritis. Am J Vet Res 1991; 52:480487.
  • 20
    Grauer GF, Frisbie DD, Longhofer SL, et al. Effects of a thromboxane synthetase inhibitor on established immune complex glomerulonephritis. Kidney Int 1990; 37:415.
  • 21
    Papanikolaou N.. Alteration of mercuric chloride-induced autoimmune glomerulonephritis in Brown-Norway rats by herring oil, evening primrose oil and OKY-046 as a selective thromboxane synthetase inhibitor. Prostaglandins Leukotrienes Med 1987; 27:129149.
  • 22
    Saito H., Idura T., Takeuchi J.. Effects of a selective thromboxane A2 synthetase inhibitor on immune complex glomerulonephritis. Nephron 1984; 36:3845.
  • 23
    Niwa T., Maeda K., Shibata M., et al. Clinical effects of a selective thromboxane A2 synthetase inhibitor in patients with ne-phrotic syndrome. Clin Nephrol 1988; 30:276281.
  • 24
    Longhofer SL, Frisbie DD, Johnson HC, et al. Effects of a thromboxane synthetase inhibitor on concanavalin A-induced glomerulonephritis. Kidney Int 1989; 35:354.
  • 25
    Green R., Kabel A.. Hypercoagulable state in three dogs with nephrotic syndrome: role of acquired antithrombin III deficiency. J Am Vet Med Assoc 1982; 181:914917.